scholarly article | Q13442814 |
P50 | author | Pedro Pechirra | Q55207385 |
Daniela Pitigoi | Q56486864 | ||
Silvia Jiménez-Jorge | Q56486868 | ||
Jean-Marie Cohen | Q88140801 | ||
Isabelle Daviaud | Q126616297 | ||
Thomas Seyler | Q29056947 | ||
Caterina Rizzo | Q37366708 | ||
Amparo Larrauri | Q41928148 | ||
Baltazar Nunes | Q42233620 | ||
P2093 | author name string | Pawel Stefanoff | |
Alain Moren | |||
Alina Elena Ivanciuc | |||
Anne-Sophie Barret | |||
Beatrix Oroszi | |||
Bruno Christian Ciancio | |||
Camelia Savulescu | |||
Esther Kissling | |||
Iwona Anna Paradowska-Stankiewicz | |||
Joan O'Donnell | |||
Judit Krisztina Horvath | |||
Marta Valenciano | |||
P2860 | cites work | Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis | Q95458203 |
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | Q21144621 | ||
Assessing heterogeneity in meta-analysis: Q statistic or I2 index? | Q29619545 | ||
First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. | Q30372912 | ||
"I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. | Q30382891 | ||
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. | Q30398764 | ||
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. | Q30399830 | ||
Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study | Q30401132 | ||
Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. | Q30404419 | ||
Two-stage methods for the analysis of pooled data | Q30655622 | ||
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls | Q33476068 | ||
Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. | Q44222661 | ||
Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009 | Q45167855 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks | Q50129178 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
influenza vaccine | Q383260 | ||
P304 | page(s) | e27622 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe | |
P478 | volume | 6 |
Q34657959 | 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. |
Q34076633 | Annual public health and economic benefits of seasonal influenza vaccination: a European estimate |
Q35211657 | Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany |
Q36957563 | Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States |
Q34532079 | Available influenza vaccines: immunization strategies, history and new tools for fighting the disease |
Q38824484 | Beliefs and attitudes towards the influenza vaccine in high-risk individuals. |
Q30367464 | Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines? |
Q39530697 | Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. |
Q38819920 | Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review |
Q41732569 | Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. |
Q34071701 | Costs and benefits of influenza vaccination: more evidence, same challenges |
Q35956533 | Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network |
Q41727440 | Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project - Monitoring Vaccine Effectiveness (I-MOVE). |
Q36887954 | Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study |
Q34993133 | Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination |
Q42228543 | Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. |
Q30367263 | Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. |
Q31161295 | Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies |
Q36251706 | Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study |
Q30420024 | Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach |
Q30428316 | Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study |
Q46200283 | Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season |
Q34786909 | Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season |
Q27009478 | Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults |
Q33891510 | Geographical heterogeneity and influenza infection within households |
Q39813822 | I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? |
Q36946436 | Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season |
Q36115609 | Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine |
Q30383312 | Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. |
Q90246622 | Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease |
Q56791503 | Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza |
Q42872289 | Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues |
Q34850986 | Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study |
Q42187912 | Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. |
Q41612054 | Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus |
Q38835739 | Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups |
Q40765540 | Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season. |
Q33554684 | Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates |
Q36956943 | Influenza vaccine effectiveness in the community and the household |
Q41934389 | Influenza vaccine use to protect healthy children: A debated topic |
Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
Q42203352 | Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study |
Q36343637 | Is the impact of childhood influenza vaccination less than expected: a transmission modelling study |
Q36148024 | Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries |
Q44243917 | Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. |
Q39422605 | Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan |
Q38907201 | Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies |
Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
Q40143693 | Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness. |
Q40042673 | Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014-2015 season in Turkey: A Test-Negative Case Control Study. |
Q42235495 | Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania |
Q30383722 | Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach |
Q41053372 | Social class based on occupation is associated with hospitalization for A(H1N1)pdm09 infection. Comparison between hospitalized and ambulatory cases. |
Q41263011 | The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q37260000 | The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings |
Q51225150 | The case test-negative design for studies of the effectiveness of influenza vaccine. |
Q30371807 | Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013 |
Q37111637 | Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season |
Q24201525 | Vaccines for preventing influenza in healthy children |
Q47638511 | Vaccines for preventing influenza in healthy children |
Q45760952 | Variable definitions of the influenza season and their impact on vaccine effectiveness estimates |
Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Q93344976 | [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] |
Search more.